The Manufacturers Life Insurance Company Trims Holdings in Encompass Health Co. (NYSE:EHC)

The Manufacturers Life Insurance Company reduced its holdings in shares of Encompass Health Co. (NYSE:EHC) by 3.6% during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 84,138 shares of the company’s stock after selling 3,137 shares during the period. The Manufacturers Life Insurance Company owned approximately 0.08% of Encompass Health worth $8,131,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently bought and sold shares of EHC. UMB Bank n.a. increased its holdings in shares of Encompass Health by 387.7% in the third quarter. UMB Bank n.a. now owns 317 shares of the company’s stock valued at $31,000 after purchasing an additional 252 shares during the period. V Square Quantitative Management LLC increased its stake in Encompass Health by 53.0% in the 3rd quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock valued at $39,000 after buying an additional 140 shares during the period. Oakworth Capital Inc. purchased a new position in Encompass Health during the 2nd quarter worth $40,000. Avior Wealth Management LLC acquired a new stake in shares of Encompass Health in the 3rd quarter worth $40,000. Finally, Benjamin F. Edwards & Company Inc. boosted its holdings in shares of Encompass Health by 58.9% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 534 shares of the company’s stock valued at $46,000 after acquiring an additional 198 shares in the last quarter. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

EHC has been the subject of several recent analyst reports. KeyCorp raised their price target on Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a report on Tuesday, October 29th. Barclays boosted their target price on shares of Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 29th. Stephens reiterated an “overweight” rating and issued a $105.00 price objective on shares of Encompass Health in a research note on Tuesday, August 6th. UBS Group upped their target price on shares of Encompass Health from $100.00 to $110.00 and gave the stock a “buy” rating in a research report on Wednesday, September 25th. Finally, Royal Bank of Canada lifted their price target on shares of Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a research report on Wednesday, October 30th. Nine equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus price target of $107.11.

Encompass Health Price Performance

Shares of NYSE EHC opened at $102.48 on Wednesday. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.88. The company has a market capitalization of $10.32 billion, a price-to-earnings ratio of 24.75, a price-to-earnings-growth ratio of 1.35 and a beta of 0.86. Encompass Health Co. has a twelve month low of $64.15 and a twelve month high of $104.55. The business has a 50 day simple moving average of $98.35 and a 200-day simple moving average of $91.57.

Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Monday, October 28th. The company reported $1.03 earnings per share for the quarter, beating analysts’ consensus estimates of $0.94 by $0.09. The business had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.33 billion. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The company’s revenue for the quarter was up 11.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.86 EPS. As a group, equities research analysts expect that Encompass Health Co. will post 4.29 earnings per share for the current year.

Encompass Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be paid a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 0.66%. The ex-dividend date of this dividend is Thursday, January 2nd. Encompass Health’s payout ratio is 16.43%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.